The double‐stained cells showed different trends in the intensity levels for CD86+/Iba‐1+ (5960.95 ± 1466.21% vs 11 520.42 ± 1279.07%, stroke/PBM and stroke/control, respectively, p < 0.001, Figure 7a,d). The gene discussed is AIF1; the disease is stroke disorder.